PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine
is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.
Event: Asia Pharma R&D Leaders Summit 2018
Keynote : Clinical Development of Tanibirumab, Its IO combination and novel IO program
-- Tanibirumab in recurrent GBM phase IIa open labelled three arms multi-center trial in Australia
-- Rationale of Tanibirumab + anti-PD1 antibody combination trials for refractory tumous
-- Development of novel IO bispecific antibody
Presentation Date: Tuesday, April 18th, 2018
Presentation Time: 10:00 - 10:30 AM
Location: InterContinental Shanghai Pudong Hotel, CHINA
For investors attending the Asia Pharma R&D Leaders Summit 2018, please contact PharmAbcine Investor Relations to schedule a meeting with
management at firstname.lastname@example.org.